![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Global X China Biotech Innovations ETF | NASDAQ:CHB | NASDAQ | Exchange Traded Fund |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.64 | 2.67 | 10.66 | 0 | 01:00:00 |
RNS Number:4018N HBOS PLC 10 July 2003 FORM 8.1/8.3 Lodge with a RIS or Newstrack if appropriate and the Takeover Panel. Use a separate form for each class of securities in which dealings have been made. Date of Disclosure 10/07/03 DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERS AND MERGERS Date of dealing 04/07/03 Dealing in (name of company) CHUBB PLC 1. Class of securities (eg ordinary shares) GBP ORD 2. Amount bought Amount sold Price per unit 79,099 #0.75 3. Resultant total of the same class owned or controlled (and percentage of class) 13,172,649 1.59% 4. Party making disclosure HBOS Plc 5. EITHER (a) Name of purchaser / vendor (Note 1) OR (b) if dealing for discretionary client(s), name of fund management organisation HBOS Plc 6. Reason for disclosure (Note 2) (a) associate of (i) offeror (Note 3) NO (ii) offeree company NO Specify which category or categories of associate (1-8 overleaf) If category (8), explain (b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more of the class of relevant securities dealt in) YES Signed, for and on behalf of the party named in (4) above (Also print name of signatory) Kaeron Heraty Telephone and Extension number 0207 321 1311 Donna Franks This information is provided by RNS The company news service from the London Stock Exchange END DCCBDGDRBGBGGXG
1 Year Global X China Biotech I... Chart |
1 Month Global X China Biotech I... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions